Newsroom

HONG KONG--(BUSINESS WIRE)--Sangfor aSV is now supported by Veeam Backup & Replication 13.1, enabling unified backup, recovery, and data protection for Sangfor HCI....

TOKYO--(BUSINESS WIRE)--Milliman, Inc., a leading global actuarial consulting firm, announced that it has obtained Type II certification as a "Certified Pseudonymized Medical Information User" in Japan. This certification is based on Japan's "Act on Anonymized and Pseudonymized Medical Information for Research and Development in the Medical Field (Next Generation Medical Infrastructure Act)," which was amended and enacted in April 2024. (nintei2026-07.pdf) This certification enables the safe ut...

MIAMI & SYDNEY, Australia--(BUSINESS WIRE)--I Squared Capital (“I Squared”), a leading independent global infrastructure investor, today announced that it has entered into a Scheme Implementation Agreement with oOh!media Limited (ASX: OML) to acquire all of its issued shares by way of a scheme of arrangement. Under the transaction, oOh!media shareholders will receive A$1.70/share1 in cash for each oOh!media share held, implying an equity value of approximately A$898 million (US$631 million2) an...

LOS ANGELES--(BUSINESS WIRE)--Faraday Future Intelligent Electric Inc. (NASDAQ: FFAI) (“Faraday Future”, “FF” or the “Company”), a California-based global Embodied AI (EAI) ecosystem company, today shared a weekly business update from YT Jia, Founder and Global CEO of FF. “Hello, everyone. Welcome to Issue 67 of our Weekly Report. Here are this week’s key highlights: On Friday, FF officially received notice that it has regained compliance with the minimum bid price requirement for continued lis...

LOS ANGELES--(BUSINESS WIRE)--PSN Investors Have Opportunity to Join Parsons Corporation Fraud Investigation with SBS Law...

LONDON--(BUSINESS WIRE)--Silence Therapeutics plc, (Nasdaq: SLN), a global clinical-stage company developing novel siRNA (short interfering RNA) therapies, today announced a conference call and webcast to discuss topline results from the Phase 2 SANRECO trial of divesiran in polycythemia vera (PV) scheduled for tomorrow, Monday, August 10, 2026 at 8:00 a.m. EDT. Investor Webcast & Conference Call Information Conference call link: https://register-conf.media-server.com/register/BI4a60039edc0...

LOS ANGELES--(BUSINESS WIRE)--NE Investors Have Opportunity to Join Noble Corporation plc Fraud Investigation with SBS Law...

LOS ANGELES--(BUSINESS WIRE)--LMB Investors Have Opportunity to Join Limbach Holdings, Inc. Fraud Investigation with SBS Law...

فيينا--(BUSINESS WIRE)--أصدرت محكمة تحكيم تابعة لغرفة التجارة الدولية حكمًا بالتعويض لصالح شركة AOP Orphan Pharmaceuticals GmbH (المشار إليها بـ "AOP Health") بإجمالي يبلغ نحو 112 مليون يورو في إجراءات التحكيم الجارية مع شركة .PharmaEssentia Cor (المشار إليها بـ "PharmaEssentia") بشأن عقار ®BESREMi ‏(ropeginterferon alfa-2b).يُحدد الحكم قيمة مطالبات الأضرار الخاصة بـ AOP Health جراء الانتهاكات المتعمدة من شركة PharmaEssentia بنحو 82 مليون يورو. كما قضى الحكم بإلزام PharmaEssentia بأن تدفع لشركة...

NEW YORK--(BUSINESS WIRE)--Bilt, the membership for where you live and the hospitality platform powering the residential ecosystem around it, today announced the expansion of Bilt OS for Hospitality to travel advisors, designed to solve the operational fragmentation that has long existed in the luxury travel advisory industry. Bilt OS for Hospitality was announced on stage at the annual Virtuoso Travel Week Tech Summit in Las Vegas, Nevada. Bilt has long prioritized travel as a key part of its...